Workflow
Metsera：诺和诺德的收购提案为"更优方案"
Novo NordiskNovo Nordisk(US:NVO) Ge Long Hui A P P·2025-10-30 11:25

Group 1 - Metsera considers Novo Nordisk's acquisition proposal as a "superior option" [1] - The bid price from Novo Nordisk is $56.50 per share in cash, plus a CVR of $21.25 per share [1]